160 related articles for article (PubMed ID: 29466356)
1. Emergence of resistance mutations in simian immunodeficiency virus (SIV)-infected rhesus macaques receiving non-suppressive antiretroviral therapy (ART).
Policicchio BB; Sette P; Xu C; Haret-Richter G; Dunsmore T; Pandrea I; Ribeiro RM; Apetrei C
PLoS One; 2018; 13(2):e0190908. PubMed ID: 29466356
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the Intactness of Persistent Viral Genomes in Simian Immunodeficiency Virus-Infected Rhesus Macaques after Initiating Antiretroviral Therapy within One Year of Infection.
Long S; Fennessey CM; Newman L; Reid C; O'Brien SP; Li Y; Del Prete GQ; Lifson JD; Gorelick RJ; Keele BF
J Virol; 2019 Dec; 94(1):. PubMed ID: 31597776
[TBL] [Abstract][Full Text] [Related]
3. Response of a simian immunodeficiency virus (SIVmac251) to raltegravir: a basis for a new treatment for simian AIDS and an animal model for studying lentiviral persistence during antiretroviral therapy.
Lewis MG; Norelli S; Collins M; Barreca ML; Iraci N; Chirullo B; Yalley-Ogunro J; Greenhouse J; Titti F; Garaci E; Savarino A
Retrovirology; 2010 Mar; 7():21. PubMed ID: 20233398
[TBL] [Abstract][Full Text] [Related]
4. Short Communication: Comparative Evaluation of Coformulated Injectable Combination Antiretroviral Therapy Regimens in Simian Immunodeficiency Virus-Infected Rhesus Macaques.
Del Prete GQ; Smedley J; Macallister R; Jones GS; Li B; Hattersley J; Zheng J; Piatak M; Keele BF; Hesselgesser J; Geleziunas R; Lifson JD
AIDS Res Hum Retroviruses; 2016 Feb; 32(2):163-8. PubMed ID: 26150024
[TBL] [Abstract][Full Text] [Related]
5. Tenofovir treatment augments anti-viral immunity against drug-resistant SIV challenge in chronically infected rhesus macaques.
Metzner KJ; Binley JM; Gettie A; Marx P; Nixon DF; Connor RI
Retrovirology; 2006 Dec; 3():97. PubMed ID: 17184540
[TBL] [Abstract][Full Text] [Related]
6. Genetic diversity of simian immunodeficiency virus encoding HIV-1 reverse transcriptase persists in macaques despite antiretroviral therapy.
Kearney M; Spindler J; Shao W; Maldarelli F; Palmer S; Hu SL; Lifson JD; KewalRamani VN; Mellors JW; Coffin JM; Ambrose Z
J Virol; 2011 Jan; 85(2):1067-76. PubMed ID: 21084490
[TBL] [Abstract][Full Text] [Related]
7. Increased Proviral DNA in Circulating Cells Correlates with Plasma Viral Rebound in Simian Immunodeficiency Virus-Infected Rhesus Macaques after Antiretroviral Therapy Interruption.
Ziani W; Shao J; Wang X; Russell-Lodrigue K; Liu YZ; Montaner LJ; Veazey RS; Xu H
J Virol; 2021 Feb; 95(6):. PubMed ID: 33408173
[TBL] [Abstract][Full Text] [Related]
8. Suppression of virus load by highly active antiretroviral therapy in rhesus macaques infected with a recombinant simian immunodeficiency virus containing reverse transcriptase from human immunodeficiency virus type 1.
North TW; Van Rompay KK; Higgins J; Matthews TB; Wadford DA; Pedersen NC; Schinazi RF
J Virol; 2005 Jun; 79(12):7349-54. PubMed ID: 15919889
[TBL] [Abstract][Full Text] [Related]
9. Two-Year Follow-Up of Macaques Developing Intermittent Control of the Human Immunodeficiency Virus Homolog Simian Immunodeficiency Virus SIVmac251 in the Chronic Phase of Infection.
Shytaj IL; Nickel G; Arts E; Farrell N; Biffoni M; Pal R; Chung HK; LaBranche C; Montefiori D; Vargas-Inchaustegui D; Robert-Guroff M; Lewis MG; Sacha JB; Palamara AT; Savarino A
J Virol; 2015 Aug; 89(15):7521-35. PubMed ID: 25972547
[TBL] [Abstract][Full Text] [Related]
10. Sequential emergence and clinical implications of viral mutants with K70E and K65R mutation in reverse transcriptase during prolonged tenofovir monotherapy in rhesus macaques with chronic RT-SHIV infection.
Van Rompay KK; Johnson JA; Blackwood EJ; Singh RP; Lipscomb J; Matthews TB; Marthas ML; Pedersen NC; Bischofberger N; Heneine W; North TW
Retrovirology; 2007 Apr; 4():25. PubMed ID: 17417971
[TBL] [Abstract][Full Text] [Related]
11. Lentiviral Infections Persist in Brain despite Effective Antiretroviral Therapy and Neuroimmune Activation.
Mohammadzadeh N; Roda W; Branton WG; Clain J; Rabezanahary H; Zghidi-Abouzid O; Gelman BB; Angel JB; Cohen EA; Gill MJ; Li M; Estaquier J; Power C
mBio; 2021 Dec; 12(6):e0278421. PubMed ID: 34903055
[TBL] [Abstract][Full Text] [Related]
12. Genetically-barcoded SIV facilitates enumeration of rebound variants and estimation of reactivation rates in nonhuman primates following interruption of suppressive antiretroviral therapy.
Fennessey CM; Pinkevych M; Immonen TT; Reynaldi A; Venturi V; Nadella P; Reid C; Newman L; Lipkey L; Oswald K; Bosche WJ; Trivett MT; Ohlen C; Ott DE; Estes JD; Del Prete GQ; Lifson JD; Davenport MP; Keele BF
PLoS Pathog; 2017 May; 13(5):e1006359. PubMed ID: 28472156
[TBL] [Abstract][Full Text] [Related]
13. Response of simian immunodeficiency virus to the novel nucleoside reverse transcriptase inhibitor 4'-ethynyl-2-fluoro-2'-deoxyadenosine in vitro and in vivo.
Murphey-Corb M; Rajakumar P; Michael H; Nyaundi J; Didier PJ; Reeve AB; Mitsuya H; Sarafianos SG; Parniak MA
Antimicrob Agents Chemother; 2012 Sep; 56(9):4707-12. PubMed ID: 22713337
[TBL] [Abstract][Full Text] [Related]
14. Residual viremia in an RT-SHIV rhesus macaque HAART model marked by the presence of a predominant plasma clone and a lack of viral evolution.
Kauffman RC; Villalobos A; Bowen JH; Adamson L; Schinazi RF
PLoS One; 2014; 9(2):e88258. PubMed ID: 24505452
[TBL] [Abstract][Full Text] [Related]
15. Analytical Treatment Interruption after Short-Term Antiretroviral Therapy in a Postnatally Simian-Human Immunodeficiency Virus-Infected Infant Rhesus Macaque Model.
Goswami R; Nelson AN; Tu JJ; Dennis M; Feng L; Kumar A; Mangold J; Mangan RJ; Mattingly C; Curtis AD; Obregon-Perko V; Mavigner M; Pollara J; Shaw GM; Bar KJ; Chahroudi A; De Paris K; Chan C; Van Rompay KKA; Permar SR
mBio; 2019 Sep; 10(5):. PubMed ID: 31488511
[TBL] [Abstract][Full Text] [Related]
16. Virulence and reduced fitness of simian immunodeficiency virus with the M184V mutation in reverse transcriptase.
Van Rompay KK; Matthews TB; Higgins J; Canfield DR; Tarara RP; Wainberg MA; Schinazi RF; Pedersen NC; North TW
J Virol; 2002 Jun; 76(12):6083-92. PubMed ID: 12021341
[TBL] [Abstract][Full Text] [Related]
17. Chronic binge alcohol consumption does not diminish effectiveness of continuous antiretroviral suppression of viral load in simian immunodeficiency virus-infected macaques.
Molina PE; Amedee AM; Veazey R; Dufour J; Volaufova J; Bagby GJ; Nelson S
Alcohol Clin Exp Res; 2014 Sep; 38(9):2335-44. PubMed ID: 25257285
[TBL] [Abstract][Full Text] [Related]
18. Origin of rebound virus in chronically SIV-infected Rhesus monkeys following treatment discontinuation.
Liu PT; Keele BF; Abbink P; Mercado NB; Liu J; Bondzie EA; Chandrashekar A; Borducchi EN; Hesselgesser J; Mish M; Chin G; Bekerman E; Geleziunas R; Barouch DH
Nat Commun; 2020 Oct; 11(1):5412. PubMed ID: 33110078
[TBL] [Abstract][Full Text] [Related]
19. Dolutegravir Monotherapy of Simian Immunodeficiency Virus-Infected Macaques Selects for Several Patterns of Resistance Mutations with Variable Virological Outcomes.
Van Rompay KKA; Hassounah S; Keele BF; Lifson JD; Ardeshir A; Watanabe J; Pham HT; Chertova E; Sowder R; Balzarini J; Mesplède T; Wainberg MA
J Virol; 2019 Jan; 93(2):. PubMed ID: 30381490
[TBL] [Abstract][Full Text] [Related]
20. A highly intensified ART regimen induces long-term viral suppression and restriction of the viral reservoir in a simian AIDS model.
Shytaj IL; Norelli S; Chirullo B; Della Corte A; Collins M; Yalley-Ogunro J; Greenhouse J; Iraci N; Acosta EP; Barreca ML; Lewis MG; Savarino A
PLoS Pathog; 2012; 8(6):e1002774. PubMed ID: 22737073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
